☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Ovranette Supply Problem

The manufacturer of Ovranette® has written to healthcare professionals to advise of a short-term difficulty affecting production that is limiting supplies. Weekly updates of supply difficulties are posted on the manufacturers website.

The product contains ethinylestradiol 30mcg and levonorgestrel 150mcg per tablet and is supplied in packs containing 63 tablets.

Microgynon 30 contains the same active ingredients and is available in the same pack size. It may therefore be a suitable alternative.

Action: Clinicians may need to prescribe alternative contraceptive medication to patients who are unable to source ovranette from pharmacies. Microgynon appears to be a suitable substitute.

Share 'Ovranette Supply Problem' by emailShare 'Ovranette Supply Problem' on FacebookShare 'Ovranette Supply Problem' on TwitterShare 'Ovranette Supply Problem' on LinkedInShare 'Ovranette Supply Problem' on reddit


No Comments to “Ovranette Supply Problem”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.